Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set

Urol Int. 2018;100(4):456-462. doi: 10.1159/000488882. Epub 2018 Apr 19.

Abstract

Objectives: The study aimed to evaluate associations of prostatic chronic inflammation (PCI) with prostate cancer (PCA) grade groups by the International Society of Urological Pathology (ISUP).

Methods: The study evaluated retrospectively 738 cases. The patient population was sampled into 3 groups collecting cases without and with PCA including subjects with lSUP grade group 1 and grade groups 2-5.

Results: PCI was assessed in 185 patients (25.1%) and PCA in 361 patients (48.9%) of whom 188 (25.5%) had ISUP grade and 173 (23.4%) had ISUP groups 2-5 tumors. PCI inversely related to ISUP groups (p < 0.0001). In multivariate analysis, the risk of ISUP grade group 1 PCA compared to negative cases associated positively with age (OR 1.042; p = 0.001) but inversely with total prostate volume (TPV; OR 0.965; p < 0.0001) and PCI (OR 0.314; p < 0.0001). Intermediate-high grade tumors associated positively with age (OR 1.065; p < 0.0001), prostate specific antigen (OR 1.167; p < 0.0001), and abnormal digital rectal examination (OR 2.251; p < 0.0001) but inversely with TPV (OR 0.921; p < 0.0001) and PCI (OR 0.106; p < 0.0001).

Conclusions: PCI decreased the risk of PCA among ISUP tumor grade groups.

Keywords: Prostate biopsy; Prostate cancer; Prostate cancer tumor grade; Prostate-specific antigen; Prostatic chronic inflammation.

MeSH terms

  • Aged
  • Biopsy*
  • Body Mass Index
  • Digital Rectal Examination
  • Humans
  • Inflammation
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Prostate / pathology
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / pathology*
  • Prostatitis / diagnosis
  • Prostatitis / pathology
  • ROC Curve
  • Regression Analysis
  • Retrospective Studies
  • Sensitivity and Specificity
  • Urology / methods*

Substances

  • Prostate-Specific Antigen